Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Bullboard Posts
Comment by Clemmie70on Jul 25, 2011 8:23am
247 Views
Post# 18867630

RE: anti cancer prevention

RE: anti cancer preventionsorry to hear that yogi. I have three dogs myself and prefer them over most of my extended family. My cousins dog had cancer and she spent hundreds and hundreds of $$ on tests and treatments to no avail. It was not even a question of cost because most of us would spend our last dime on our "companion pets". They are there for us at our worst, so it's the least we could do.

I too am very excited about all CFR has to offer. They are/ will be enjoying a revenue stream from the sale and promotion of their companion pet products, and in the meantime, they will continue testing with their other product lines. As already proven, this growth will come with private and government funding to expedite the process. And after reading some of the articles this past weekend on www.fiercepharma.com I wouldn't be surprised to see a pharma jump onboard.

Cheers and a great week to all
Bullboard Posts